Novartis
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$212.7M
Focus Areas
3
Top Stage
Pre-clinical
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Atrium Therapeutics | $212.7M |
| Mariana Oncology | — |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| Atrium Therapeutics | $212.7M |
| Mariana Oncology | — |